Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge Healthcare), and Danaher.
The global PCR and realtime PCR testing market is expected to decline from $22.53 billion in 2020 to $9.98 billion in 2021 at a compound annual growth rate (CAGR) of -55.7%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $13.82 billion in 2025 at a CAGR of 8.5%.
The polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market consists of sales of PCR and real –time PCR testing services and its related products.Polymerase chain reaction (PCR) and Real time Polymerase chain reaction (PCR) testing establishments manufacture, develop or deploy the related devices, reagents and services, to detect and measure the DNA (or RNA) in a sample.
It finds its applications in cloning, genotyping, mutation testing, paternity testing, sequencing and microarrays.
The polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market covered in this report is segmented by product into consumables and reagents, instruments, software and services; by application into clinical diagnostics, life science research, industrial applications, others; by technology into quantitative PCR, digital PCR and by end-use into academic and research institutes, pharmaceutical and biotechnology, clinical diagnostics labs and hospitals, others.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The need for early detection of chronic diseases is expected to drive the market.With the onset of chronic diseases, there has been a priority to detect the cause of the disease to decrease its onset on people, for the drug discovery and to start the appropriate treatment at the appropriate time, which enables faster cure and also save maximum lives and decreases its after-effects.
The RT-PCR test is the standard test for the recent COVID-19 (corona virus) pandemic.It is used for its high sensitivity, which enables it to detect early infection.
Therefore, the need for early detection is propelling the PCR and real time PCR testing market.
Development of alternative technologies is expected to hinder the growth of PCR and real time PCR testing market.New technologies such as CRISPR, which is a rapid test is expected to be launched soon.
In February 2020, Sherlock Biosciences Inc. and Mammoth Biosciences are trying to launch improved diagnostics with CRISPR-based technologies that would increase and accelerate the detection of the corona virus to treat the patients better and also to control the further spread of the virus. Development of alternative tests is expected to hinder the PCR and Real Time PCR Testing market.
Early detection plays a key role in treating COVID-19 patients.The real time RT-PCR technique is a highly sensitive and specific testing method that can deliver a reliable diagnosis in as fast as three hours, unlike the other laboratory tests that take an average of 6 to 8 hours.
Real time RT-PCR is significantly faster and has a lower potential for contamination or errors as the entire process is within a closed tube.Therefore, currently it is considered to be the most accurate method available for detection of the coronavirus.
This has created huge demand for PCR testing kits.
The companies in the PCR and RT PCR Testing market are coming up with new test kits and systems for the diagnosis of diseases.In January 2020, Roche got CE Mark approved for adenovirus test for the transplant patients.
It is designed to be used along with other infectious diseases tests which can be used in their 6800 and 8800 cobas systems. Most companies are coming with the Real time RT-PCR test for corona virus, contributing to the growth of the PCR and Real time PCR Testing market.
The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Our reports have been used by over 10K customers, including:
The companion, animal diagnostics market, is projected to reach USD 3.0 billion by 2025 from USD 1.8 billion in 2020, at a CAGR of 9.8%. The rising companion animal population, increasing demand for pet insurance, and the growth in the number of veterinary practitioners in developed economies are the major factors that are driving the growth...
Global Microbiology Market, 2019-2023: Supplier Shares and Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics This new report is a seven-country strategic...
INTRODUCTION The introduction of personalized medicine has brought about a paradigm shift within the healthcare sector. Over the years, many cases have been identified where conventional treatment options have failed to demonstrate any therapeutic benefit. It is estimated that nearly 50% of prescribed drugs / therapies...
Leading Companies, Trends and Developments in the Growing Theranostics Market Report Details What can be expected from the Companion Diagnostics market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2028, assessing data, trends, opportunities...
MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts
Companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy.
Companion diagnostic test market is growing, particularly in the...
Report Details What can be expected from the Companion Diagnostics market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there. Our 192-page report provides 127 tables, charts, and graphs. Discover the most...
Summary Arkray, Inc. (Arkray), formerly KDK Corporation is a medical device company that offers diagnostic products. The company offers diagnostic products and equipments for diabetes diagnosis and urinalysis applications. Its products comprise automatic glycohemoglobin analyzer for diabetes, automated analyzers for clinical...
Summary Given Imaging Ltd. (Given Imaging) is a gastrointestinal (GI) medical device company and one of the leading companies in the capsule endoscopy domain. It develops, manufactures, and markets innovative diagnostic products for use in visualization and detection of gastrointestinal (GI) tract disorders. The company's flagship...
Summary Agendia NV (Agendia) is a molecular diagnostic company that develops and markets FFPE-based genomic diagnostic products. The company discovers, develops and commercializes products for the treatment of cancer. Its products comprise mammaprint, blueprint, targetprint, coloprint, theraprint for breast cancer, theraprint...
Summary MP Biomedicals LLC (MP Biomedicals), formerly ICN Biomedicals is a diagnostic company that manufactures and markets life science, fine chemical and diagnostic products. Its life science products include adsorbents, antibodies and immunoreagents, apoptosis, biochemicals and reagents, culture media and reagents, kits and...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.